The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Michael Haude
Showing 1-20 of 66 articles
EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI). A branch of the European Society of Cardiology.
Van Belle E,
Teles R,
Pyxaras S,
Kalpak O,
Johnson T,
Barbash I,
De Luca G,
Kostov J,
Parma R,
Vincent F,
Brugaletta S,
Debry N,
Toth G,
Ghazzal Z,
Deharo P,
Milasinovic D,
Kaspar K,
Saia F,
Mauri Ferre J,
Kammler J,
Muir D,
O'Connor S,
Mehilli J,
Thiele H,
Weilenmann D,
Witt N,
Joshi F,
Kharbanda R,
Piroth Z,
Wojakowski W,
Geppert A,
Di Gioia G,
Pires-Morais G,
Petronio A,
Estévez-Loureiro R,
Ruzsa Z,
Kefer J,
Kunadian V,
Van Mieghem N,
Windecker S,
Baumbach A,
Haude M,
Dudek D
May 16, 2021 | 10.4244/EIJ-D-18-00448
Impact of clinical and haemodynamic factors on coronary flow reserve and invasive coronary flow capacity in non-obstructed coronary arteries: a patient-level pooled analysis of the DEBATE and ILIAS studies
Stegehuis V,
Wijntjens G,
Bax M,
Meuwissen M,
Chamuleau S,
Voskuil M,
Koch K,
Di Mario C,
Vrints C,
Haude M,
Boersma E,
Serruys P,
Piek J,
van de Hoef T
April 2, 2021 | 10.4244/EIJ-D-19-00774
Computed tomography angiography imaging of the Carillon device topography after unsuccessful treatment of functional mitral regurgitation
Rottländer D,
Gödde M,
Degen H,
Haude M
March 19, 2021 | 10.4244/EIJ-D-20-00332
Preclinical investigation of neoatherosclerosis in magnesium-based bioresorbable scaffolds versus thick-strut drug-eluting stents
Nicol P,
Bulin A,
Castellanos M,
Stöger M,
Obermeier S,
Lewerich J,
Lenz T,
Hoppmann P,
Baumgartner C,
Fischer J,
Steiger K,
Haude M,
Joner M
December 4, 2020 | 10.4244/EIJ-D-19-00747
Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
Onuma Y,
Chevalier B,
Ono M,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabaté M,
Windecker S,
Rapoza R,
West N,
Reith S,
de Sousa Almeida M,
Campo G,
Iniguez-Romo A,
Serruys P
December 4, 2020 | 10.4244/EIJ-D-20-00024
Reply: Cardiac CT prior to percutaneous coronary sinus-based mitral annuloplasty with the Carillon device
Rottländer D,
Gödde M,
Degen H,
Haude M
November 20, 2020 | 10.4244/EIJ-D-20-00621R
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K,
Chichareon P,
Modolo R,
Kogame N,
Chang C,
Tomaniak M,
Moschovitis A,
Curzen N,
Haude M,
Jung W,
Holmvang L,
Garg S,
Tijssen J,
Wykrzykowska J,
de Winter R,
Hamm C,
Steg P,
Stoll H,
Onuma Y,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial
Haude M,
Ince H,
Toelg R,
Lemos P,
von Birgelen C,
Christiansen E,
Wijns W,
Neumann F,
Eeckhout E,
Garcia-Garcia H,
Waksman R
February 7, 2020 | 10.4244/EIJ-D-18-01000
Twelve-month outcomes of 400 patients treated with a resorbable metal scaffold: insights from the BIOSOLVE-IV registry
Verheye S,
Wlodarczak A,
Montorsi P,
Bennett J,
Torzewski J,
Haude M,
Vrolix M,
Buck T,
Aminian A,
van der Schaaf R,
Nuruddin A,
Lee M
February 7, 2020 | 10.4244/EIJ-D-18-01058
BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months
Saito S,
Toelg R,
Witzenbichler B,
Haude M,
Masotti M,
Salmeron R,
Witkowski A,
Uematsu M,
Takahashi A,
Waksman R,
Slagboom T
December 6, 2019 | 10.4244/EIJ-D-18-01214
Evolving paradigms in valvular heart disease: where should guidelines move?
Baumbach A,
Dudek D,
Baumgartner H,
Windecker S,
Haude M
November 15, 2019 | 10.4244/EIJ-D-19-00818
Coronary sinus to mitral valve annulus topography and response to the percutaneous coronary sinus-based mitral valve contour system
Rottländer D,
Schneider T,
Degen H,
Laufenberg M,
Chatrou M,
Haude M
November 15, 2019 | 10.4244/EIJ-D-19-00054
Patient focus in interventional cardiology: proceedings of the 2018 summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) – Nice, France, 20-21 June 2018
Barbato E,
Mauri Ferre J,
Byrne R,
Roffi M,
Fitzsimons D,
Toth G,
Capodanno D,
Mehilli J,
Petronio A,
Chieffo A,
Vardas P,
Naber C,
Dudek D,
Haude M,
Baumbach A
April 16, 2019 | 10.4244/EIJV14I17A297
Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina
Schueler R,
Al-Lamee R,
Mahfoud F,
Capodanno D,
Asnag M,
Haude M
October 19, 2018 | 10.4244/EIJY18M09_2
Preclinical evaluation of degradation kinetics and elemental mapping of first- and second-generation bioresorbable magnesium scaffolds
Joner M,
Ruppelt P,
Zumstein P,
Lapointe-Corriveau C,
Leclerc G,
Bulin A,
Castellanos M,
Wittchow E,
Haude M,
Waksman R
October 12, 2018 | 10.4244/EIJ-D-17-00708
Welcome to PCR London Valves 2018: 10th Anniversary Edition
Barbanti M,
Prendergast B,
Haude M,
Piazza N,
Windecker S,
Baumbach A,
Tamburino C
September 7, 2018 | 10.4244/EIJV14SABA1
Evaluating the importance of sham-controlled trials in the investigation of medical devices in interventional cardiology
Byrne R,
Capodanno D,
Mahfoud F,
Fajadet J,
Windecker S,
Jüni P,
Baumbach A,
Wijns W,
Haude M
August 24, 2018 | 10.4244/EIJ-D-18-00481
EAPCI Presidential “criss-cross”
Baumbach A,
Haude M
May 20, 2018 | 10.4244/EIJV14I1A7
May in Paris! Join us! EuroPCR 2018
Haude M
April 20, 2018 | 10.4244/EIJV13I17A326
Answering the challenges of the New Year – the EAPCI in 2018
Haude M
January 19, 2018 | 10.4244/EIJV13I13A243
1
2
3
…
4
Latest news
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
EUROPCR LATE BREAKING
SavvyWire in TAVI
FREE ARTICLE - Josep Rodés-Cabau et al
May 24, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke